所在位置: 首页> 产品目录> Quidel>

Quidel Normal Human Complement

产品名称：Quidel Normal Human Complement
产品型号： A112
产品厂商：Quidel
产品文档：

你添加了1件商品查看购物车

简单介绍

Quidel Normal Human Complement

的详细介绍

产品介绍

品名
Quidel Normal Human Complement

货号
A112 / A113

规格
Two sizes: 2.5 mL and 5.0 mL

形式
Frozen Liquid

储存
At or below –70°C

使用说明
For Research Use Only. Not for use in diagnostic procedures.

描述
Normal human serum characterized for levels of complement activation fragments Human Serum Complement is intended for use expressly in experiments to assess levels of in vitro complement activation or complement cytotoxicity. It has been characterized in the Quidel Complement Activation Assays for levels of Bb, C4d, C3a, iC3b, and TCC as well as for total CH50.

This product is intended for use in an experimental setting specifically for monitoring in vitro complement activation. It is therefore appropriate for use in biocompatibility experiments including drug development, biomaterials testing and other applications where the effects of complement need to be monitored. This product contains no EDTA.

储存
This product should be stored at or below –70°C. When needed, it should be thawed rapidly at 37°C and immediately placed on ice until use. Any remaining sera should be aliquotted into polypropylene tubes in a convenient volume and re-frozen at –70°C or below. Avoid repeated freeze thaw. Storage at temperatures warmer than –70°C is not recommended.

应用
Normal human serum complement is suitable for in vitro experiments relating to complement activation. It has been widely used in biomaterials research, pharmaceutical development and cytotoxicity *****s. It is ideal for experiments and *****s for which a high level of in vitro complement activity is necessary or a low level of complement activation fragments is required.

参考资料
1、Idusogie, E. E., Presta, L., et al. Mapping of the C1q binding site on Rituxan, a chimeric antibody with a human IgG1 FC. J. Immunol 164:4178- 4184 (2000).

2、Hinton, PR., Xiong, J., et al An Engineered Human IgG1 Antibody with Longer Serum HalfLife. J Immunol 176:346-356 (2006).

3、Dall’Acqua, W.F., Cook, K.E., et al. Modulation of the Effector Functions of a Human IgG1 through Engineering of Its Hinge Region. J Immunol 177:1129-1138 (2006).

标题：

内容：

联系人：

联系电话：

Email：

公司名称：

联系地址：

注：1.可以使用快捷键Alt+S或Ctrl+Enter发送信息!

2.如有必要,请您留下您的详细联系方式!

产品介绍
品名	Quidel Normal Human Complement
货号	A112 / A113
规格	Two sizes: 2.5 mL and 5.0 mL
形式	Frozen Liquid
储存	At or below –70°C
使用说明	For Research Use Only. Not for use in diagnostic procedures.
描述	Normal human serum characterized for levels of complement activation fragments Human Serum Complement is intended for use expressly in experiments to assess levels of in vitro complement activation or complement cytotoxicity. It has been characterized in the Quidel Complement Activation Assays for levels of Bb, C4d, C3a, iC3b, and TCC as well as for total CH50. This product is intended for use in an experimental setting specifically for monitoring in vitro complement activation. It is therefore appropriate for use in biocompatibility experiments including drug development, biomaterials testing and other applications where the effects of complement need to be monitored. This product contains no EDTA.
储存	This product should be stored at or below –70°C. When needed, it should be thawed rapidly at 37°C and immediately placed on ice until use. Any remaining sera should be aliquotted into polypropylene tubes in a convenient volume and re-frozen at –70°C or below. Avoid repeated freeze thaw. Storage at temperatures warmer than –70°C is not recommended.
应用	Normal human serum complement is suitable for in vitro experiments relating to complement activation. It has been widely used in biomaterials research, pharmaceutical development and cytotoxicity ***s. It is ideal for experiments and ***s for which a high level of in vitro complement activity is necessary or a low level of complement activation fragments is required.
参考资料	1、Idusogie, E. E., Presta, L., et al. Mapping of the C1q binding site on Rituxan, a chimeric antibody with a human IgG1 FC. J. Immunol 164:4178- 4184 (2000). 2、Hinton, PR., Xiong, J., et al An Engineered Human IgG1 Antibody with Longer Serum HalfLife. J Immunol 176:346-356 (2006). 3、Dall’Acqua, W.F., Cook, K.E., et al. Modulation of the Effector Functions of a Human IgG1 through Engineering of Its Hinge Region. J Immunol 177:1129-1138 (2006).